GPT and Hyperbilirubinemia: These complications were linked to hepatotoxicity directly related to hepatocellular damage (as demonstrated by the increase in hepatic cytonecrosis parameters such as AST/ALT) and the cholestatic injury caused by the drug (as evidenced by hyperbilirubinemia and increased ALP).